Experienced in Homocystinuria due to MTHFR Deficiency

Esmeralda G. Martins-Gomes

Santo Antonio De Felheiros, PT 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Homocystinuria due to MTHFR Deficiency
Santo Antonio De Felheiros, PT 
OverviewLocationsClinical Research

Overview

Esmeralda Martins-Gomes practices in Santo Antonio De Felheiros, Portugal. Ms. Martins-Gomes is rated as an Experienced expert by MediFind in the treatment of Homocystinuria due to MTHFR Deficiency. Her top areas of expertise are Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Glutaric Acidemia Type 2.

Her clinical research consists of co-authoring 50 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Homocystinuria due to MTHFR Deficiency.

Gender
Female

Locations

Santo Antonio De Felheiros, Portugal
Other Locations
Porto, 4050313, Portugal
Boavista, 4050111, Portugal

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Enrollment Status: Recruiting
Publish Date: May 08, 2025
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7
A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7
Enrollment Status: Completed
Publish Date: July 30, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

50 Total Publications

Protein intake and prevalence of overweight in patients with phenylketonuria: A 10-year longitudinal study.
Protein intake and prevalence of overweight in patients with phenylketonuria: A 10-year longitudinal study.
Journal: Molecular genetics and metabolism
Published: December 23, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Martins-Gomes's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile